Cargando…

Establishment of the circadian metabolic phenotype strategy in spontaneously hypertensive rats: a dynamic metabolomics study

BACKGROUND: Circadian rhythms play a fundamental role in the progression of cardiovascular events. Almost all cardiovascular diseases have a circadian misalignment usually characterized by changes in metabolites. This study aimed to dynamically monitor rhythmic biomarkers, to elucidate the metabolic...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Huanjun, Wang, Xiaoming, Qi, Dongmei, Sun, Mengjia, Hou, Qingqing, Li, Yunlun, Jiang, Haiqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988197/
https://www.ncbi.nlm.nih.gov/pubmed/31992312
http://dx.doi.org/10.1186/s12967-020-02222-1
_version_ 1783492215597694976
author Wang, Huanjun
Wang, Xiaoming
Qi, Dongmei
Sun, Mengjia
Hou, Qingqing
Li, Yunlun
Jiang, Haiqiang
author_facet Wang, Huanjun
Wang, Xiaoming
Qi, Dongmei
Sun, Mengjia
Hou, Qingqing
Li, Yunlun
Jiang, Haiqiang
author_sort Wang, Huanjun
collection PubMed
description BACKGROUND: Circadian rhythms play a fundamental role in the progression of cardiovascular events. Almost all cardiovascular diseases have a circadian misalignment usually characterized by changes in metabolites. This study aimed to dynamically monitor rhythmic biomarkers, to elucidate the metabolic pathways that are potentially under circadian control in spontaneously hypertensive rats (SHRs), and to eventually establish a circadian metabolic phenotype strategy based on metabolomics. METHODS: In this study, an untargeted metabolomics technology was used to dynamically monitor changes in serum metabolites between SHR model group and WKY control group. Liquid chromatography-mass spectrometry (LC–MS) combined with multivariate statistical analysis was applied to identify markers of hypertension rhythm imbalance. The concentrations of amino acids and their metabolites identified as markers were quantified by a subsequent targeted metabolomics analysis. Overall, these approaches comprehensively explored the rhythm mechanism and established a circadian metabolic phenotype strategy. RESULTS: The metabolic profile revealed a disorder in the diurnal metabolism pattern in SHRs. Moreover, multivariate statistical analysis revealed metabolic markers of rhythm homeostasis, such as arginine, proline, phenylalanine, citric acid, l-malic acid, succinic acid, etc., accompanied by an imbalance in hypertension. The key metabolic pathways related to rhythm imbalance in hypertension were found by enrichment analysis, including amino acid metabolism, and the tricarboxylic acid cycle (TCA). In addition, the quantitative analysis of amino acids and their metabolites showed that the changes in leucine, isoleucine, valine, taurine, serine, and glycine were the most obvious. CONCLUSIONS: In summary, this study illustrated the relationship between metabolites and the pathways across time on hypertension. These results may provide a theoretical basis for personalized treatment programmes and timing for hypertension.
format Online
Article
Text
id pubmed-6988197
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-69881972020-01-31 Establishment of the circadian metabolic phenotype strategy in spontaneously hypertensive rats: a dynamic metabolomics study Wang, Huanjun Wang, Xiaoming Qi, Dongmei Sun, Mengjia Hou, Qingqing Li, Yunlun Jiang, Haiqiang J Transl Med Research BACKGROUND: Circadian rhythms play a fundamental role in the progression of cardiovascular events. Almost all cardiovascular diseases have a circadian misalignment usually characterized by changes in metabolites. This study aimed to dynamically monitor rhythmic biomarkers, to elucidate the metabolic pathways that are potentially under circadian control in spontaneously hypertensive rats (SHRs), and to eventually establish a circadian metabolic phenotype strategy based on metabolomics. METHODS: In this study, an untargeted metabolomics technology was used to dynamically monitor changes in serum metabolites between SHR model group and WKY control group. Liquid chromatography-mass spectrometry (LC–MS) combined with multivariate statistical analysis was applied to identify markers of hypertension rhythm imbalance. The concentrations of amino acids and their metabolites identified as markers were quantified by a subsequent targeted metabolomics analysis. Overall, these approaches comprehensively explored the rhythm mechanism and established a circadian metabolic phenotype strategy. RESULTS: The metabolic profile revealed a disorder in the diurnal metabolism pattern in SHRs. Moreover, multivariate statistical analysis revealed metabolic markers of rhythm homeostasis, such as arginine, proline, phenylalanine, citric acid, l-malic acid, succinic acid, etc., accompanied by an imbalance in hypertension. The key metabolic pathways related to rhythm imbalance in hypertension were found by enrichment analysis, including amino acid metabolism, and the tricarboxylic acid cycle (TCA). In addition, the quantitative analysis of amino acids and their metabolites showed that the changes in leucine, isoleucine, valine, taurine, serine, and glycine were the most obvious. CONCLUSIONS: In summary, this study illustrated the relationship between metabolites and the pathways across time on hypertension. These results may provide a theoretical basis for personalized treatment programmes and timing for hypertension. BioMed Central 2020-01-28 /pmc/articles/PMC6988197/ /pubmed/31992312 http://dx.doi.org/10.1186/s12967-020-02222-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wang, Huanjun
Wang, Xiaoming
Qi, Dongmei
Sun, Mengjia
Hou, Qingqing
Li, Yunlun
Jiang, Haiqiang
Establishment of the circadian metabolic phenotype strategy in spontaneously hypertensive rats: a dynamic metabolomics study
title Establishment of the circadian metabolic phenotype strategy in spontaneously hypertensive rats: a dynamic metabolomics study
title_full Establishment of the circadian metabolic phenotype strategy in spontaneously hypertensive rats: a dynamic metabolomics study
title_fullStr Establishment of the circadian metabolic phenotype strategy in spontaneously hypertensive rats: a dynamic metabolomics study
title_full_unstemmed Establishment of the circadian metabolic phenotype strategy in spontaneously hypertensive rats: a dynamic metabolomics study
title_short Establishment of the circadian metabolic phenotype strategy in spontaneously hypertensive rats: a dynamic metabolomics study
title_sort establishment of the circadian metabolic phenotype strategy in spontaneously hypertensive rats: a dynamic metabolomics study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988197/
https://www.ncbi.nlm.nih.gov/pubmed/31992312
http://dx.doi.org/10.1186/s12967-020-02222-1
work_keys_str_mv AT wanghuanjun establishmentofthecircadianmetabolicphenotypestrategyinspontaneouslyhypertensiveratsadynamicmetabolomicsstudy
AT wangxiaoming establishmentofthecircadianmetabolicphenotypestrategyinspontaneouslyhypertensiveratsadynamicmetabolomicsstudy
AT qidongmei establishmentofthecircadianmetabolicphenotypestrategyinspontaneouslyhypertensiveratsadynamicmetabolomicsstudy
AT sunmengjia establishmentofthecircadianmetabolicphenotypestrategyinspontaneouslyhypertensiveratsadynamicmetabolomicsstudy
AT houqingqing establishmentofthecircadianmetabolicphenotypestrategyinspontaneouslyhypertensiveratsadynamicmetabolomicsstudy
AT liyunlun establishmentofthecircadianmetabolicphenotypestrategyinspontaneouslyhypertensiveratsadynamicmetabolomicsstudy
AT jianghaiqiang establishmentofthecircadianmetabolicphenotypestrategyinspontaneouslyhypertensiveratsadynamicmetabolomicsstudy